Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P3 is a processed pseudogene located at human chromosome 12q23.3 (genomic coordinates 12:106015897-106017006)[2]. It is named for its sequence similarity to the ST13 gene, which encodes the Hsp70 interacting protein (Hip), a co-chaperone involved in protein folding, but ST13P3 itself does not produce a functional protein and has no established biological function or disease relevance[2][6][7][8]. If you are looking for a true therapeutic target, such as the functional parent gene ST13 ("Suppression of tumorigenicity 13"), this encodes the Hsp70 interacting protein (Hip), which acts as a co-chaperone in protein folding and has been investigated in the context of cancer biology, among other processes[4][9]. However, ST13P3 is a non-functional pseudogene with no current relevance as a therapeutic target.
None documented for therapeutic agents, as it is not a protein-coding target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 3 (ST13P3).